ZTS Zoetis Inc

Price (delayed)

$169.78

Market cap

$80.67B

P/E Ratio

49.35

Dividend/share

$0.9

EPS

$3.44

Enterprise value

$84.43B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights

ZTS's equity is up by 39% year-on-year and by 4.6% since the previous quarter
Zoetis's quick ratio has increased by 28% YoY and by 10% QoQ
The debt rose by 11% YoY but it fell by 6% QoQ
The P/E is 29% higher than the 5-year quarterly average of 38.0 and 15% higher than the last 4 quarters average of 42.6

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
475.17M
Market cap
$80.67B
Enterprise value
$84.43B
Valuations
Price to earnings (P/E)
49.35
Price to book (P/B)
21.41
Price to sales (P/S)
12.09
EV/EBIT
37.88
EV/EBITDA
31.62
EV/Sales
12.65
Earnings
Revenue
$6.68B
EBIT
$2.23B
EBITDA
$2.67B
Free cash flow
$1.67B
Per share
EPS
$3.44
Free cash flow per share
$3.52
Book value per share
$7.93
Revenue per share
$14.04
TBVPS
$19.36
Balance sheet
Total assets
$13.61B
Total liabilities
$9.84B
Debt
$7.36B
Equity
$3.77B
Working capital
$4.44B
Liquidity
Debt to equity
1.95
Current ratio
3.05
Quick ratio
2.13
Net debt/EBITDA
1.41
Margins
EBITDA margin
40%
Gross margin
69.2%
Net margin
24.5%
Operating margin
33.4%
Efficiency
Return on assets
12.6%
Return on equity
50%
Return on invested capital
20.6%
Return on capital employed
19.5%
Return on sales
33.4%
Dividend
Dividend yield
0.53%
DPS
$0.9
Payout ratio
26.2%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
0.42%
1 week
1.28%
1 month
8.81%
1 year
37.32%
YTD
2.59%
QTD
7.81%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$6.68B
Gross profit
$4.62B
Operating income
$2.23B
Net income
$1.64B
Gross margin
69.2%
Net margin
24.5%
Zoetis's operating income has increased by 10% YoY
The net income has grown by 9% YoY
The gross profit has grown by 8% YoY
ZTS's revenue is up by 7% YoY and by 2% QoQ

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
49.35
P/B
21.41
P/S
12.09
EV/EBIT
37.88
EV/EBITDA
31.62
EV/Sales
12.65
The P/E is 29% higher than the 5-year quarterly average of 38.0 and 15% higher than the last 4 quarters average of 42.6
Zoetis's EPS has increased by 10% YoY
ZTS's equity is up by 39% year-on-year and by 4.6% since the previous quarter
The stock's price to book (P/B) is 8% more than its 5-year quarterly average of 19.8
ZTS's price to sales (P/S) is 52% higher than its 5-year quarterly average of 7.9 and 13% higher than its last 4 quarters average of 10.7
ZTS's revenue is up by 7% YoY and by 2% QoQ

Efficiency

How efficient is Zoetis business performance
The company's return on equity fell by 16% YoY and by 9% QoQ
ZTS's return on assets is down by 6% year-on-year and by 5% since the previous quarter
ZTS's ROIC is up by 4% YoY but it is down by 2.8% QoQ
Zoetis's return on sales has increased by 3.4% YoY but it has decreased by 2.6% QoQ

Dividends

What is ZTS's dividend history
DPS
$0.9
Dividend yield
0.53%
Payout ratio
26.2%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 38% greater than its total liabilities
Zoetis's quick ratio has increased by 28% YoY and by 10% QoQ
ZTS's total assets is up by 18% year-on-year
The debt is 95% higher than the equity
ZTS's equity is up by 39% year-on-year and by 4.6% since the previous quarter
Zoetis's debt to equity has decreased by 20% YoY and by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.